India, April 13 -- The matter of augmenting the basket of vaccines available for fighting the pandemic as well as to accelerate the pace & coverage of domestic vaccination programme was discussed in the 23rdmeeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) held on 11thApril 2021, chaired by Dr. V K Paul, Member (Health), Niti Aayog.

The NEGVAC, after comprehensive deliberation, recommended that vaccines for COVID-19, which have been developed & are being manufactured in foreign countries and which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO(Emergency Use Listing) may be granted emergency use approval in India, mandating the requir...